Skip to main content
. 2013 Mar 28;81(2):309–327. doi: 10.3797/scipharm.1302-08

Fig. 11.

Fig. 11

Triazoles and N-acylated thiosemicarbazide inhibitors of VIM-2 and IMP-1 MBLs